Evolving pathway-driven biomarkers in breast cancer

Expert Opinion on Investigational Drugs

Volumn 19, Issue SUPPL. 1, 2010, Pages

  Ohshiro, Kazufumi ^a   Kumar, Rakesh ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Biomarker; Breast cancer; Coactivator; Corepressor; Estrogen receptor; Nuclear receptor

Indexed keywords

BIOLOGICAL MARKER; CYTOPLASM PROTEIN; CYTOSKELETON PROTEIN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; NUCLEAR RECEPTOR COREPRESSOR; P21 ACTIVATED KINASE 1; TAMOXIFEN;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL DECISION MAKING; CONFERENCE PAPER; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; MOLECULE; NONHUMAN; PROGNOSIS; PROTEIN PHOSPHORYLATION; PROTEOMICS; SIGNAL TRANSDUCTION; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CYTOPLASM; DECISION MAKING; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; P21-ACTIVATED KINASES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 77950646690     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543781003718817     Document Type: Conference Paper

References (27)

1. McKenna NJ, O'Malley BW. Nuclear receptors, coregulators, ligands, and selective receptor modulators: making sense of the patchwork quilt. Ann NY Acad Sci 2001;949:3-5
2. Morley P, Whitfield JF, Vanderhyden BC, et al. A new, nongenomic estrogen action: the rapid release of intracellular calcium. Endocrinology 1992;131:1305-1312
3. Jakacka M, Ito M, Martinson F, et al. An estrogen receptor (ER) alpha deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo. Mol Endocrinol 2002;16:2188-2201
4. Guo X, Razandi M, Pedram A, et al. Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors alpha and beta. J Biol Chem 2005;280:19704-19710
5. Migliaccio A, Di Domenico M, Castoria G, et al. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 1996;15:1292-1300
6. Zhang Z, Kumar R, Santen RJ, et al. The role of adapter protein Shc in estrogen non-genomic action. Steroids 2004;69:523-529
7. Simoncini T, Hafezi-Moghadam A, Brazil DP, et al. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000;407:538-541
8. Ahmad S, Singh N, Glazer RI. Role of AKT1 in 17beta-estradiol-and insulin-like growth factor I (IGF-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells. Biochem Pharmacol 1999;58:425-430
9. Lee YR, Park J, Yu HN, et al. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells. Biochem Biophys Res Commun 2005;336:1221-1226
10. Planas-Silva MD, Shang Y, Donaher JL, et al. AIB1 enhances estrogen-dependent induction of cyclin D1 expression. Cancer Res 2001;61:3858-3862
11. Vadlamudi RK, Wang RA, Mazumdar A, et al. Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha. J Biol Chem 2001;276:38272-38279
12. Rayala SK, den Hollander P, Balasenthil S, et al. Functional regulation of oestrogen receptor pathway by the dynein light chain 1. EMBO Rep 2005;6:538-544
13. Gururaj AE, Peng S, Vadlamudi RK, et al. Estrogen induces expression of BCAS3, a novel estrogen receptor-alpha coactivator, through proline-, glutamic acid-, and leucine-rich protein-1 (PELP1). Mol Endocrinol 2007;21:1847-1860
14. Mazumdar A, Wang RA, Mishra SK, et al. Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat Cell Biol 2001;3:30-37
15. Gururaj AE, Singh RR, Rayala SK, et al. MTA1, a transcriptional activator of breast cancer amplified sequence 3. Proc Natl Acad Sci USA 2006;103:6670-6675
16. Gururaj AE, Holm C, Landberg G, et al. Breast cancer-amplified sequence 3, a target of metastasis-associated protein 1, contributes to tamoxifen resistance in premenopausal patients with breast cancer. Cell Cycle 2006;5:1407-1410
17. Vadlamudi RK, Balasenthil S, Broaddus RR, et al. Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors. J Clin Endocrinol Metab 2004;89:6130-6138
18. Vadlamudi RK, Manavathi B, Balasenthil S, et al. Functional implications of altered subcellular localization of PELP1 in breast cancer cells. Cancer Res 2005;65:7724-7732
19. Vadlamudi RK, Balasenthil S, Sahin AA, et al. Novel estrogen receptor coactivator PELP1/MNAR gene and ERbeta expression in salivary duct adenocarcinoma: potential therapeutic targets. Hum Pathol 2005;36:670-675
20. Wong CW, McNally C, Nickbarg E, et al. Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci USA 2002;99:14783-14788
21. Vadlamudi RK, Manavathi B, Balasenthil S, et al. Functional implications of altered subcellular localization of PELP1 in breast cancer cells. Cancer Res 2005;65:7724-7732
22. Kumar R, Gururaj AE, Barnes CJ. p21-activated kinases in cancer. Nat Rev Cancer 2006;6:459-471
23. Balasenthil S, Sahin AA, Barnes CJ, et al. p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells. J Biol Chem 2004;279:1422-1428
24. Balasenthil S, Barnes CJ, Rayala SK, et al. Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells. FEBS Lett 2004;567:243-247
25. Holm C, Rayala S, Jirstrom K, et al. Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients. J Natl Cancer Inst 2006;98:671-680
26. Rayala SK, Talukder AH, Balasenthil S, et al. P21-activated kinase 1 regulation of estrogen receptor-alpha activation involves serine 305 activation linked with serine 118 phosphorylation. Cancer Res 2006;66:1694-1701
27. Vadlamudi RK, Li F, Barnes CJ, et al. p41-Arc subunit of human Arp2/3 complex is a p21-activated kinase-1-interacting substrate. EMBO Rep 2004;5:154-160